Loading
companiesCompany
Certis Oncology Solutions
Certis grows pieces of a patient's tumour in mice and in the lab to test which drugs work, serving both drug developers and oncologists looking for treatment options for an individual patient.
Overview
Certis Oncology Solutions, based at 5626 Oberlin Drive, San Diego, is a translational science company operating under the Oncology Intelligence brand. For drug developers it offers patient-derived xenograft (PDX) cancer models, custom model development, in vitro and ex vivo pharmacology, in vivo pharmacology, imaging and endpoint analysis, immuno-oncology studies and CertisAI, a predictive analytics layer built on its model bank. For oncologists and patients it offers Order Your PDX, a service that establishes a PDX from an individual patient's tumour and tests candidate therapies to inform treatment choice, supported by clinical research and patient education resources. The website is rendered client-side and only navigation and address text could be extracted, so founding year, funding and case numbers could not be confirmed from primary sources.
Notes
top- Only navigation and footer text could be extracted from the JavaScript-rendered site; services list and HQ are verified, but founding year, funding and stage are not (stage is a guess).
Similar pages
- IdeaZebrafish avatars for a drug answer within a week
Shares Patient-derived xenografts, Functional (ex vivo) drug testing.
- IdeaScore every model system on how well it predicted real trial results
Shares Patient-derived xenografts, AI-driven drug & target discovery.
- IdeaAutomated combination discovery: patient-sample screens feeding Bayesian platform trials
Shares Functional (ex vivo) drug testing, AI-driven drug & target discovery.
- IdeaRun the mouse or organoid trial at the same time as the human trial
Shares Patient-derived xenografts, Functional (ex vivo) drug testing.
- IdeaA funded organoid and PDX panel as the go/no-go gate before IND-enabling money
Shares Patient-derived xenografts, Functional (ex vivo) drug testing.
- IdeaGrow blood-borne tumour cells to test drugs on the cells that actually spread
Shares Patient-derived xenografts, Functional (ex vivo) drug testing.
- TermOrganoid
Shares Patient-derived xenografts, Functional (ex vivo) drug testing.
- IdeaAn open model bank for the rare tumours nobody has models for
Shares Patient-derived xenografts, Functional (ex vivo) drug testing.